Zusammenfassung
Die Bestimmung des hochsensitiven Troponins ist der Goldstandard bei Patienten mit akutem Thoraxschmerz und erlaubt die zeitnahe Diagnosestellung und Therapieeinleitung bei Patienten mit akutem Myokardinfarkt (AMI). Erhöhte kardiale Troponinspiegel sind hochspezifisch für das Vorliegen einer akuten myokardialen Schädigung. Hingegen beruht nicht jede myokardiale Schädigung auf einem AMI, sodass bei der Interpretation erhöhter Troponinspiegel immer die Klinik und das 12-Kanal-Elektrokardiogramm mitberücksichtigt werden müssen. Neben dem AMI finden sich bei zahlreichen Erkrankungen erhöhte Troponinspiegel, sodass nicht jeder Patient zwangsläufig einer invasiven Koronardiagnostik unterzogen werden muss.
Abstract
The determination of high-sensitivity troponin remains the gold standard in patients with acute chest pain and allows the early diagnosis and therapy of patients with acute myocardial infarction (AMI). Increased cardiac troponin levels are highly specific for myocardial damage. However, elevated troponin levels are not equivalent to AMI and therefore the clinical presentation and the electrocardiogram of each patient must be taken into account. Elevated troponin levels are found in numerous diseases but not every patient needs invasive coronary angiography.
Literatur
Adler C, Reuter H (2014) Ableitung aVR in der kardialen Notfalldiagnostik. Kardiologe 8(5):415–418. https://doi.org/10.1007/s12181-014-0593-9
Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio ALP, de Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P (2017) ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J 38(3):143–153. https://doi.org/10.1093/eurheartj/ehw149
Andersson HB, Pedersen F, Engstrøm T, Helqvist S, Jensen MK, Jørgensen E, Kelbæk H, Räder SBEW, Saunamäki K, Bates E, Grande P, Holmvang L, Clemmensen P (2018) Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease. Eur Heart J 39(2):102–110. https://doi.org/10.1093/eurheartj/ehx491
Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH, Davies SW, Pennell DJ, Prasad SK (2007) The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 28(10):1242–1249. https://doi.org/10.1093/eurheartj/ehm113
Babuin L, Vasile VC, Rio PJA, Alegria JR, Chai H‑S, Afessa B, Jaffe AS (2008) Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med 36(3):759–765. https://doi.org/10.1097/CCM.0B013E318164E2E4
Becattini C, Vedovati MC, Agnelli G (2007) Prognostic value of troponins in acute pulmonary embolism. A meta-analysis. Circulation 116(4):427–433. https://doi.org/10.1161/CIRCULATIONAHA.106.680421
Christ M, Popp S, Pohlmann H, Poravas M, Umarov D, Bach R, Bertsch T (2010) Implementation of high sensitivity cardiac troponin T measurement in the emergency department. Am J Med 123(12):1134–1142. https://doi.org/10.1016/j.amjmed.2010.07.015
Christ M, Dormann H, Enk R, Popp S, Singler K, Müller C, Mang H (2014) Chest pain units oder chest-pain-algorithmus? Med Klin Intensivmed Notfmed 109(7):495–503. https://doi.org/10.1007/s00063-013-0342-z
Dierkes J, Domröse U, Westphal S, Ambrosch A, Bosselmann HP, Neumann KH, Luley C (2000) Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 102(16):1964–1969
Diris JHC, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser MP (2004) Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 109(1):23–25. https://doi.org/10.1161/01.CIR.0000109483.45211.8F
Everett BM, Brooks MM, Vlachos HEA, Chaitman BR, Frye RL, Bhatt DL (2015) Troponin and cardiac events in stable Ischemic heart disease and diabetes. N Engl J Med 373(7):610–620. https://doi.org/10.1056/NEJMoa1415921
Fournier S, Iten L, Marques-Vidal P, Boulat O, Bardy D, Beggah A, Calderara R, Morawiec B, Lauriers N, Monney P, Iglesias JF, Pascale P, Harbaoui B, Eeckhout E, Muller O (2017) Circadian rhythm of blood cardiac troponin T concentration. Clin Res Cardiol 106(12):1026–1032. https://doi.org/10.1007/s00392-017-1152-8
Heymans S (2007) Myocarditis and heart failure. Need for better diagnostic, predictive, and therapeutic tools. Eur Heart J 28(11):1279–1280. https://doi.org/10.1093/eurheartj/ehm111
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177. https://doi.org/10.1093/eurheartj/ehx393
Jaffe AS, Babuin L, Apple FS (2006) Biomarkers in acute cardiac disease. The present and the future. J Am Coll Cardiol 48(1):1–11. https://doi.org/10.1016/j.jacc.2006.02.056
Kelley WE, Januzzi JL, Christenson RH (2009) Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 55(12):2098–2112. https://doi.org/10.1373/clinchem.2009.130799
Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A (2005) Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease. A meta-analysis. Circulation 112(20):3088–3096. https://doi.org/10.1161/CIRCULATIONAHA.105.560128
Konstantinides S, Geibel A, Olschewski M, Kasper W, Hruska N, Jäckle S, Binder L (2002) Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106(10):1263–1268
Konstantinides SV (2008) Acute pulmonary embolism revisited. Thromboembolic venous disease. Heart 94(6):795–802. https://doi.org/10.1136/hrt.2005.071274
Kontos MC, Diercks DB, Kirk JD (2010) Emergency department and office-based evaluation of patients with chest pain. Mayo Clin Proc 85(3):284–299. https://doi.org/10.4065/mcp.2009.0560
Lauer B, Niederau C, Kühl U, Schannwell M, Pauschinger M, Strauer BE, Schultheiss HP (1997) Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 30(5):1354–1359
Martínez-Sellés M, Bueno H, Sacristán A, Estévez A, Ortiz J, Gallego L, Fernández-Avilés F (2008) Chest pain in the emergency department. Incidence, clinical characteristics and risk stratification. Rev Esp Cardiol 61(9):953–959
Mueller C, Giannitsis E, Christ M, Ordóñez-Llanos J, deFilippi C, McCord J, Body R, Panteghini M, Jernberg T, Plebani M, Verschuren F, French J, Christenson R, Weiser S, Bendig G, Dilba P, Lindahl B (2016) Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med 68(1):76–87.e4. https://doi.org/10.1016/j.annemergmed.2015.11.013
Ndrepepa G, Colleran R, Braun S, Cassese S, Hieber J, Fusaro M, Kufner S, Ott I, Byrne RA, Husser O, Hengstenberg C, Laugwitz K‑L, Schunkert H, Kastrati A (2016) High-sensitivity troponin T and mortality after elective percutaneous coronary intervention. J Am Coll Cardiol 68(21):2259–2268. https://doi.org/10.1016/j.jacc.2016.08.059
Niccoli G, Scalone G, Crea F (2015) Acute myocardial infarction with no obstructive coronary atherosclerosis. Mechanisms and management. Eur Heart J 36(8):475–481. https://doi.org/10.1093/eurheartj/ehu469
O’Shaughnessy MM, Liu S, Montez-Rath ME, Lafayette RA, Winkelmayer WC (2018) Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis. A retrospective analysis. Eur Heart J. https://doi.org/10.1093/eurheartj/ehy422
Parmacek MS, Solaro RJ (2004) Biology of the troponin complex in cardiac myocytes. Prog Cardiovasc Dis 47(3):159–176
Rahman A, Broadley SA (2014) Review article. Elevated troponin: diagnostic gold or fool’s gold? Emerg Med Australas 26(2):125–130. https://doi.org/10.1111/1742-6723.12203
Roffi M, Patrono C, Collet J‑P, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267–315. https://doi.org/10.1093/eurheartj/ehv320
Roos A, Bandstein N, Lundbäck M, Hammarsten O, Ljung R, Holzmann MJ (2017) Stable high-sensitivity cardiac Troponin T levels and outcomes in patients with chest pain. J Am Coll Cardiol 70(18):2226–2236. https://doi.org/10.1016/j.jacc.2017.08.064
Sgarbossa EB, Pinski SL, Barbagelata A, Underwood DA, Gates KB, Topol EJ, Califf RM, Wagner GS (1996) Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med 334(8):481–487. https://doi.org/10.1056/NEJM199602223340801
Shah ASV, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, Cruikshank A, Reid A, Stoddart M, Strachan F, Walker S, Collinson PO, Apple FS, Gray AJ, Fox KAA, Newby DE, Mills NL (2015) High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women. Prospective cohort study. BMJ 350:g7873. https://doi.org/10.1136/bmj.g7873
Smith SC, Ladenson JH, Mason JW, Jaffe AS (1997) Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95(1):163–168
Stangl R, Paul C, Söntgerath A, Adler C (2019) Fulminante Lungenembolie mit erfolgreicher präklinischer Reanimation nach Lyse und vollständiger Restitutio ad integrum. Notfall Rettungsmed 22(1):45–50. https://doi.org/10.1007/s10049-018-0463-2
Stripe B, Rechenmacher S, Jurewitz D, Lee C, Schaefer S (2013) The diagnostic yield of cardiac catheterization in low-risk troponinemia. JAMA Intern Med 173(22):2088–2090. https://doi.org/10.1001/jamainternmed.2013.11109
Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. Eur Heart J 33(20):2551–2567. https://doi.org/10.1093/eurheartj/ehs184
Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C (2012) High-sensitive troponin T measurements. What do we gain and what are the challenges? Eur Heart J 33(5):579–586. https://doi.org/10.1093/eurheartj/ehr492
Twerenbold R, Wildi K, Jaeger C, Gimenez MR, Reiter M, Reichlin T, Walukiewicz A, Gugala M, Krivoshei L, Marti N, Moreno Weidmann Z, Hillinger P, Puelacher C, Rentsch K, Honegger U, Schumacher C, Zurbriggen F, Freese M, Stelzig C, Campodarve I, Bassetti S, Osswald S, Mueller C (2015) Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction. Circulation 131(23):2041–2050. https://doi.org/10.1161/CIRCULATIONAHA.114.014245
Ukena C, Kindermann M, Mahfoud F, Geisel J, Lepper PM, Kandolf R, Böhm M, Kindermann I (2014) Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis. Clin Res Cardiol 103(9):743–751. https://doi.org/10.1007/s00392-014-0709-z
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Baldus erhielt Vortragshonorare von Edwards Lifesciences, Bayer Vital, CVRx, MSD SHARP & DOHME GmbH, JenaValve Technology und Abbott sowie Fördermittel von IcoVifor, Symetis SA, Pfizer, JenaValve Technology, Valtech, OptumInsight, Biotronik und Abbott außerhalb der vorliegenden Arbeit. C. Adler gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
M. Buerke, Siegen
Rights and permissions
About this article
Cite this article
Adler, C., Baldus, S. Troponinerhöhung – benötigt jeder Patient eine Koronarangiographie?. Med Klin Intensivmed Notfmed 115, 690–698 (2020). https://doi.org/10.1007/s00063-019-0593-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-019-0593-4